Key Highlights: Implications: The expansion makes Turbhe more competitive for high-potency peptides, HPAPIs, and biomolecules, helping Piramal attract programs that need safe, sm...
Latest Developments on GLP-1 Therapies In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as one of the fastest-growing segments in the global pharmaceutical market....
Key Highlights: Implications: MSN joins the generics stampede, slashing premium GLP-1 prices and handing endocrinologists budget-friendly options for mass diabetes management.&n...
